BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1712151)

  • 1. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics.
    Thomas DM; Hillis AN; Coles GA; Davies M; Williams JD
    Am J Kidney Dis; 1991 Jul; 18(1):38-43. PubMed ID: 1712151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor.
    Erley CM; Harrer U; Krämer BK; Risler T
    Kidney Int; 1992 May; 41(5):1297-303. PubMed ID: 1614045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of enalapril in hypertensive patients with glomerulonephritis.
    Grazi G; Cirami C; Panichi V; Bianchi AM; Parrini M; Baronti A; Cominotto R; Montagnani E; Palla R
    Nephrol Dial Transplant; 1989; 4(5):396-8. PubMed ID: 2549456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of proteinuria by angiotensin converting enzyme inhibition.
    Heeg JE; de Jong PE; van der Hem GK; de Zeeuw D
    Kidney Int; 1987 Jul; 32(1):78-83. PubMed ID: 3041097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease.
    Apperloo AJ; de Zeeuw D; Sluiter HE; de Jong PE
    BMJ; 1991 Oct; 303(6806):821-4. PubMed ID: 1932973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy.
    Ambalavanan S; Fauvel JP; Sibley RK; Myers BD
    J Am Soc Nephrol; 1996 Feb; 7(2):290-8. PubMed ID: 8785399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.
    Remuzzi A; Schieppati A; Battaglia C; Remuzzi G
    Am J Kidney Dis; 1989 Sep; 14(3):170-7. PubMed ID: 2476029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreases of proteinuria during alternate-day prednisone therapy in nephrotic syndrome.
    Wetzels JF; Hoitsma AJ; Koene RA
    Nephrol Dial Transplant; 1990; 5(11):914-9. PubMed ID: 2127825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of antihypertensives on proteinuria: angiotensin-converting enzyme inhibitor versus alpha 1-antagonist.
    Rosenberg ME; Hostetter TH
    Am J Kidney Dis; 1991 Oct; 18(4):472-82. PubMed ID: 1656730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term therapy with enalapril in patients with nephrotic-range proteinuria.
    Proesmans W; Wambeke IV; Dyck MV
    Pediatr Nephrol; 1996 Oct; 10(5):587-9. PubMed ID: 8897561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of enalapril on urinary protein excretion in patients with idiopathic membranous nephropathy.
    Sauter ER; Bakris GL
    J Clin Pharmacol; 1990 Feb; 30(2):155-8. PubMed ID: 2312767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of diurnal rhythms in glomerular permeability in patients with membranous nephropathy.
    Koopman MG; Arisz L
    Nephrol Dial Transplant; 1997; 12 Suppl 2():47-52. PubMed ID: 9269700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of ciclosporin on renal hemodynamics and urinary protein excretion in patients with the nephrotic syndrome.
    Fuiano G; Conte G; Sepe V; Balletta M; Cianfrone P; Libetta C; Romano G; Sabbatini M; Bisesti V
    Nephron; 1991; 59(3):369-74. PubMed ID: 1758524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril improved renal function and proteinuria in chronic glomerulopathies.
    Ferder LF; Inserra F; Daccordi H; Smith RD
    Nephron; 1990; 55 Suppl 1():90-5. PubMed ID: 2345596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrendipine and amlodipine mimic the acute effects of enalapril on renal haemodynamics and reduce glomerular hyperfiltration in patients with chronic kidney disease.
    Morrone LF; Ramunni A; Fassianos E; Saracino A; Coratelli P; Passavanti G
    J Hum Hypertens; 2003 Jul; 17(7):487-93. PubMed ID: 12821956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.